NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Remedly

Remedly

Private
Oakland, CaliforniaHealthcare & Life Scienceshttps://www.remedly.com

Last Round

Series A

Feb 26, 2021

Total Funding Raised

$985,000

Company Overview

Remedly is a developer of healthcare software designed to streamline clinical workflows and improve patient care. The company provides an all-in-one, cloud-based platform that combines Electronic Health Records (EHR), Revenue Cycle Management (RCM), and Practice Management solutions. The software is tailored for growing specialty practices, including Mental and Behavioral Health, Medical Aesthetics, Plastic Surgery, and Durable Medical Equipment (DME). Key features include patient scheduling, HIPAA-compliant communication, medical billing, and performance analytics, enabling healthcare practitioners to reduce administrative work and focus on patient care.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, EHR & EMR, Revenue Cycle, Patient Engagement, Telemedicine

Business Model

B2B

Customer Profile

Subscription SaaS, Payment Processing Fee, Services & Consulting

AI Layer

Non-AI

Keywords

practice management softwareelectronic health recordsEHRrevenue cycle managementRCMmedical billing softwareplastic surgery EHRmedical spa softwaremental health EHRclinic OSpatient portaltelehealth platformvertical SaaSe-prescribingeRxdermatology EHRpatient engagement platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Remedly Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Remedly Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 26, 2021
AcceleratorMar 9, 2017
SeedMar 9, 2017

Key People

Founding team and executive leadership

Alexander Alishoev

CTO

Executive Team

Remedly Investors

Notable investors and investment history

InvestorRounds
StartXAccelerator
FCA Venture PartnersSeries A
Ulu VenturesSeries A
LEO Innovation LabSeed, Accelerator
HealthboxAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2025

    Included on Capterra's 2025 Best EHR for Mental Health Shortlist.

  • Feb 11, 2025

    Received "Best Of Customer Support" badge from Software Advice.

Remedly Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Remedly Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Remedly's valuation, stock price, and market status.

Firmographic Details

HeadquartersOakland, California
Employee Range12
Year Founded2012
Last FundingFeb 26, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.